MONCTON, NEW BRUNSWICK -- (Marketwired) -- 10/14/14

OrganiGram Holdings Inc. (TSX VENTURE:OGI)(PINKSHEETS:OGRMF) (the "Company") is pleased announce that its facility based in Moncton, NB, is the first medical marijuana production facility in Canada to receive internationally recognized organic certification. The company received its organic certification on October 10, 2014 from ECOCERT.

ECOCERT provides inspection and certification for sustainable development. The certification process includes validation of ingredients, production methods and preparation procedures according to Canadian and USDA regulation. Organic certification aims to guarantee the organic integrity of products throughout the entire production chain.

Randy Fleming, Master Grower states, "Growing organically allows us to provide our customers with the highest quality, chemical free medicine possible. We achieve this without the use of pesticides, synthetic nutrients, and without irradiation or cold pasteurization. Growing our product organically allows us to release the plants full genetic potential, delivering complex terpene profiles our customers will find very appealing."

ECOCERT is one of the world leaders in the certification of organic farming products. Accredited by USDA for the NOP (National Organic Programme) and MAFF for JAS in Japan, as well as being approved by many countries on the basis of national regulations, ECOCERT ensures access to organic farming markets.

ECOCERT's basic task consists in guaranteeing the rigorous respect of the applied standards on products, systems or services. The issuance of the certificate acts as a security for the consumer or the user.

About OrganiGram Holdings Inc.

OrganiGram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, OrganiGram Inc., is a licensed producer of medical marijuana in Canada. OrganiGram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. OrganiGram's facility is located in Moncton, New Brunswick and the Company is regulated by the Marihuana for Medical Purposes Regulations.

Please visit www.organigram.ca for more information.

On Behalf of the Board of Directors of OrganiGram,

Denis Arsenault, Chief Executive Officer

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts:
OrganiGram Holdings Inc.
Brett Allan
Director of Investor Relations
(416) 907-4148
brett@organigram.ca
www.organigram.ca